89 related articles for article (PubMed ID: 23765343)
1. Evaluation of putative anti-cryptosporidial drugs in an in vitro culture system.
Schupfner M; Greif G; Lendner M; Daugschies A; Lippuner C; von Samson-Himmelstjerna G; Krücken J
Parasitol Res; 2013 Aug; 112 Suppl 1():149-62. PubMed ID: 23765343
[TBL] [Abstract][Full Text] [Related]
2. Development of a Cytopathic Effect-Based Phenotypic Screening Assay against Cryptosporidium.
Chao AT; Lee BH; Wan KF; Selva J; Zou B; Gedeck P; Beer DJ; Diagana TT; Bonamy GMC; Manjunatha UH
ACS Infect Dis; 2018 Apr; 4(4):635-645. PubMed ID: 29341586
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of chitosan, a natural polysaccharide, against Cryptosporidium parvum in vitro and in vivo in neonatal mice.
Mammeri M; Chevillot A; Thomas M; Polack B; Julien C; Marden JP; Auclair E; Vallée I; Adjou KT
Exp Parasitol; 2018 Nov; 194():1-8. PubMed ID: 30237052
[TBL] [Abstract][Full Text] [Related]
4. Application of quantitative real-time reverse transcription-PCR in assessing drug efficacy against the intracellular pathogen Cryptosporidium parvum in vitro.
Cai X; Woods KM; Upton SJ; Zhu G
Antimicrob Agents Chemother; 2005 Nov; 49(11):4437-42. PubMed ID: 16251280
[TBL] [Abstract][Full Text] [Related]
5. Combination of cell culture and quantitative PCR for screening of drugs against Cryptosporidium parvum.
Shahiduzzaman M; Dyachenko V; Obwaller A; Unglaube S; Daugschies A
Vet Parasitol; 2009 Jun; 162(3-4):271-7. PubMed ID: 19342176
[TBL] [Abstract][Full Text] [Related]
6. High-Throughput Screening of Drugs Against the Growth of Cryptosporidium parvum In Vitro by qRT-PCR.
Zhang H; Zhu G
Methods Mol Biol; 2020; 2052():319-334. PubMed ID: 31452170
[TBL] [Abstract][Full Text] [Related]
7. In vitro assessment of anticryptosporidial efficacy and cytotoxicity of adenosine analogues using a SYBR Green real-time PCR method.
Arai T; Kimata I; Kitade Y; Nakamoto K; Tokoro M
J Antimicrob Chemother; 2011 Mar; 66(3):560-3. PubMed ID: 21393228
[TBL] [Abstract][Full Text] [Related]
8. Defining Stage-Specific Activity of Potent New Inhibitors of Cryptosporidium parvum Growth
Funkhouser-Jones LJ; Ravindran S; Sibley LD
mBio; 2020 Mar; 11(2):. PubMed ID: 32127445
[No Abstract] [Full Text] [Related]
9. [Highly Active AntiRetroviral Therapy and cryptosporidiosis].
Morales Gomez MA
Parassitologia; 2004 Jun; 46(1-2):95-9. PubMed ID: 15305695
[TBL] [Abstract][Full Text] [Related]
10. Modulation of gene expression of three Cryptosporidium parvum ATP-binding cassette transporters in response to drug treatment.
Benitez AJ; McNair N; Mead J
Parasitol Res; 2007 Nov; 101(6):1611-6. PubMed ID: 17705063
[TBL] [Abstract][Full Text] [Related]
11. Novel and promising compounds to treat Cryptosporidium parvum infections.
Graczyk Z; Chomicz L; Kozłowska M; Kazimierczuk Z; Graczyk TK
Parasitol Res; 2011 Sep; 109(3):591-4. PubMed ID: 21344209
[TBL] [Abstract][Full Text] [Related]
12. Novel lactate dehydrogenase inhibitors with in vivo efficacy against Cryptosporidium parvum.
Li K; Nader SM; Zhang X; Ray BC; Kim CY; Das A; Witola WH
PLoS Pathog; 2019 Jul; 15(7):e1007953. PubMed ID: 31356619
[TBL] [Abstract][Full Text] [Related]
13. A high-throughput phenotypic screen identifies clofazimine as a potential treatment for cryptosporidiosis.
Love MS; Beasley FC; Jumani RS; Wright TM; Chatterjee AK; Huston CD; Schultz PG; McNamara CW
PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005373. PubMed ID: 28158186
[TBL] [Abstract][Full Text] [Related]
14. Specific and quantitative detection and identification of Cryptosporidium hominis and C. parvum in clinical and environmental samples.
Yang R; Murphy C; Song Y; Ng-Hublin J; Estcourt A; Hijjawi N; Chalmers R; Hadfield S; Bath A; Gordon C; Ryan U
Exp Parasitol; 2013 Sep; 135(1):142-7. PubMed ID: 23838581
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Calcium-Dependent Protein Kinase 1 (CDPK1) In Vitro by Pyrazolopyrimidine Derivatives Does Not Correlate with Sensitivity of Cryptosporidium parvum Growth in Cell Culture.
Kuhlenschmidt TB; Rutaganira FU; Long S; Tang K; Shokat KM; Kuhlenschmidt MS; Sibley LD
Antimicrob Agents Chemother; 2016 Jan; 60(1):570-9. PubMed ID: 26552986
[TBL] [Abstract][Full Text] [Related]
16. Antiparasitic activity of flavonoids and isoflavones against Cryptosporidium parvum and Encephalitozoon intestinalis.
Mead J; McNair N
FEMS Microbiol Lett; 2006 Jun; 259(1):153-7. PubMed ID: 16684116
[TBL] [Abstract][Full Text] [Related]
17. Assessment of drugs against Cryptosporidium parvum using a simple in vitro screening method.
Armson A; Meloni BP; Reynoldson JA; Thompson RC
FEMS Microbiol Lett; 1999 Sep; 178(2):227-33. PubMed ID: 10499272
[TBL] [Abstract][Full Text] [Related]
18. Enzyme immunoassay detection of Cryptosporidium parvum inhibition by sinefungin in sporozoite infected HCT-8 enterocytic cells.
Gargala G; Delaunay A; Favennec L; Brasseur P; Ballet JJ
Int J Parasitol; 1999 May; 29(5):703-9. PubMed ID: 10404264
[TBL] [Abstract][Full Text] [Related]
19. A screening pipeline for antiparasitic agents targeting cryptosporidium inosine monophosphate dehydrogenase.
Sharling L; Liu X; Gollapalli DR; Maurya SK; Hedstrom L; Striepen B
PLoS Negl Trop Dis; 2010 Aug; 4(8):e794. PubMed ID: 20706578
[TBL] [Abstract][Full Text] [Related]
20. Targeted gene knockdown validates the essential role of lactate dehydrogenase in Cryptosporidium parvum.
Witola WH; Zhang X; Kim CY
Int J Parasitol; 2017 Nov; 47(13):867-874. PubMed ID: 28606696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
